Viatris Inc
VTRS
$18.09+3.70%
Delayed · as of Oct 15, 2026, 2:01 PM ET
Mkt cap
$10.83B
EV/Sales
1.67
P/E ratio
N/A
FY2025 Revenue
$14.30B
EPS (TTM)
$-0.37
Gross Margin (FY2025)
35.06%
Profit Margin (FY2025)
-24.58%
Beta
0.89
Div yield
5.38%
Sector
Healthcare
Viatris Inc (VTRS) is a drug manufacturers - specialty & generic company listed on US.
Latest reported VTRS revenue for 2025-12-31 was $14.30B. Net income was -$3.51B. Revenue was down 3.0% from 2024-12-31 to 2025-12-31. VTRS currently screens at market cap $10.83B.
Use this VTRS research hub for sector, financials, and filings — not a live tape.
Latest cached year on this hub. Full VTRS income, balance, and cash tables.
† Total Debt: Derived: short-term debt plus long-term debt (no total debt stored).
Viatris Inc (VTRS) is a drug manufacturers - specialty & generic company in the Healthcare sector.
Latest cached Viatris Inc (VTRS) revenue for Dec 31, 2025 was $14.30B. Net income was -$3.51B. Statements: https://lician.com/financials/vtrs
Viatris Inc (VTRS) market capitalization is $10.83B on the latest cached snapshot.
Viatris Inc (VTRS) cached previous close $17.44; day range $17.73 – $18.09; volume 3,532,671. Session quote: https://lician.com/quote/vtrs
Viatris Inc (VTRS) latest cached earnings event is "VTRS earnings" on Aug 6, 2026. Earnings calendar: https://lician.com/earnings
The latest cached VTRS filing is 8-K · Oct 8, 2026. Filings: https://lician.com/sec/vtrs